Compare ORGO & CVGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORGO | CVGW |
|---|---|---|
| Founded | 1985 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 348.6M | 466.0M |
| IPO Year | 2016 | 2002 |
| Metric | ORGO | CVGW |
|---|---|---|
| Price | $2.67 | $25.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $7.67 | ★ $33.50 |
| AVG Volume (30 Days) | ★ 666.3K | 168.5K |
| Earning Date | 05-29-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.18% |
| EPS Growth | 1600.00 | ★ 1950.00 |
| EPS | 0.15 | ★ 1.11 |
| Revenue | $564,169,000.00 | ★ $648,434,000.00 |
| Revenue This Year | N/A | $3.49 |
| Revenue Next Year | $17.84 | $11.23 |
| P/E Ratio | ★ $17.80 | $22.67 |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $2.61 | $18.40 |
| 52 Week High | $7.08 | $28.72 |
| Indicator | ORGO | CVGW |
|---|---|---|
| Relative Strength Index (RSI) | 23.82 | 40.07 |
| Support Level | $2.61 | $24.22 |
| Resistance Level | $5.08 | $27.14 |
| Average True Range (ATR) | 0.22 | 0.57 |
| MACD | -0.06 | -0.27 |
| Stochastic Oscillator | 3.28 | 2.79 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Calavo Growers Inc is engaged in the sourcing, packing, and distribution of fresh avocados, tomatoes, and papayas, and the processing of guacamole and other avocado products. The company delivers products to retail grocers, club and mass-merchandise stores, foodservice operators, and wholesalers, sourcing avocados from California, Mexico, and other key growing regions. Its operations include sorting, packing, ripening, and shipping fresh produce, and processing and packaging fresh and frozen guacamole. The company operates through two segments: Fresh, including avocados, tomatoes, papayas, and other fresh produce products, and Prepared, including guacamole and avocado pulp, with the majority of revenue generated from the Fresh segment and geographically from the United States.